Positron emission tomography and functional characterization of a complete PBR/TSPO knockout
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The evolutionarily conserved peripheral benzodiazepine receptor (PBR), or 18-kDa translocator protein (TSPO), is thought to be essential for cholesterol transport and steroidogenesis, and thus life. TSPO has been proposed as a biomarker of neuroinflammation and a new drug target in neurological diseases ranging from Alzheimer’s disease to anxiety. Here we show that global C57BL/6- Tspo tm1GuWu(GuwiyangWurra) -knockout mice are viable with normal growth, lifespan, cholesterol transport, blood pregnenolone concentration, protoporphyrin IX metabolism, fertility and behaviour. However, while the activation of microglia after neuronal injury appears to be unimpaired, microglia from GuwiyangWurra TSPO knockouts produce significantly less ATP, suggesting reduced metabolic activity. Using the isoquinoline PK11195, the ligand originally used for the pharmacological and structural characterization of the PBR/TSPO, and the imidazopyridines CLINDE and PBR111, we demonstrate the utility of GuwiyangWurra TSPO knockouts to provide robust data on drug specificity and selectivity, both in vitro and in vivo , as well as the mechanism of action of putative TSPO-targeting drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confirmation of global Tspo knockout mice with immunostaining. (a) Anti-TSPO antibody staining showed the presence of TSPO (here shown in the kidney and testis) in the wild-type and absence in the knockout Tspo−/− mice. The slides were the same as previously used for autoradiography with the selective TSPO-binding ligand [3H]PK11195 (Fig. 4). (b) Antibody staining of Tspo+/+ and Tspo+/− macrophages validates mitochondria as the primary site of the TSPO, which is entirely absent in Tspo−/− mice. No obvious difference in intracellular density or distribution of the mitochondria was detected in the Tspo−/− mice (green=TSPO; red=mitochondria; yellow=merged image; blue=nucleus; scale bars: (a) 500 μm and (b) 20 μm).](https://figures.cochat.ai/paper-figures/489dfd31193042a89714e7a6b7fcf5b0/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-2.jpg)
![Figure 3 No constitutive TSPO ligand binding in Tspo−/− mice. (a) Tspo+/+, Tspo+/− and Tspo−/− mice are identical in external appearance and general behaviour. However, in vivo imaging (8 males of the same age for each genotype) with PET/CT using the radioligand [18F]PBR111, the 18F-labelled analogue to [125I]CLINDE, strikingly illustrates that (apart from occasional signals originating from the excretory pathways, such as gut and urinary bladder) Tspo−/− mice show no ligand binding (thus also demonstrating the selectivity of the used ligand), while both Tspo+/+ and Tspo+/− mice have the characteristic distribution of ligand binding, that is, in organs with known high TSPO expression, notably kidney and adrenal gland (green circle). The images are displayed with the colour scaling and are directly comparable (highest values are white). The time-point frame of the PET images is 15–20 min after injection and scaling is 3.8–17.9% ID per cm3. (b) The kinetics of [18F]PBR111, and the displacement of the radioligand after injection (indicated by arrows) with cold PBR111 (1 mM) to establish non-specific binding, demonstrates that Tspo−/− mice do not have specific binding of [18F]PBR111 in any organs, while the ligand kinetic in Tspo+/+ and Tspo+/− mice indicates specific binding (ID= injected dose; n=4 for each genotype; error bars denote standard deviation).](https://figures.cochat.ai/paper-figures/dd26686107704770842176e62bb3174b/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-3.jpg)
![Figure 4 Comparative receptor autoradiography and membrane binding. (a–f) The receptor autoradiographs (16 μm sections) show total binding of [3H]PK11195 (1 nM) and [125I]CLINDE (3 nM) as well as competitive binding with 10 μM unlabelled CLINDE (CB(CL)), PK11195 (CB(PK)) and PBR111 (CB(PBR)) in the spleens (a,b), kidneys (c,d) and testes (e,f) of Tspo+/+, Tspo+/− and Tspo−/− mice. Specific binding of 3 nM [125I]CLINDE and 1 nM [3H]PK11195 is clearly visible in tissue sections from Tspo+/+ and Tspo+/− mice and is displaceable by the unlabelled ligands. There is no specific binding in Tspo−/− tissue. (g,h) Specific binding using [3H]PK11195 in testicular tissue (g) and kidney tissue (h) (n=3 for each genotype Tspo+/+, Tspo+/− and Tspo−/−). Tspo+/− mice (kidney (Bmax and Kd): 45,361.0 fmol per mg and 5.94 nM; testes: 3,696.0 fmol per mg and 7.32 nM) have approximately half the binding of Tspo+/+mice (kidney: 108,934.0 fmol per mg and 12.90 nM; testes: 4,920.0 fmol per mg and 2.66 nM) while Tspo−/−mice have no appreciable binding. Curves represent non-linear regression of experimentally obtained data points and data are expressed as percentage relative to Tspo+/+ specific binding. Error bars denote standard deviation.](https://figures.cochat.ai/paper-figures/b49242ad71a7481da1038c79e23b1cd0/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-4.jpg)
![Figure 5 Whole-body receptor autoradiography of neonatal mice. Receptor autoradiography using the TSPO ligand [125I]CLINDE on whole bodies of 2-day-old neonatal mice. The autoradiographs show total binding of [125I]CLINDE (3 nM) as well as competitive displacement binding with 10 μM unlabelled CLINDE (CB(CL)), PK11195 (CB(PK)) and PBR111 (CB(PBR)). Specific binding of [125I]CLINDE is clearly visible in the Tspo+/+ mice and is displaceable by all three unlabelled ligands. Non-specific binding is seen in areas of nuchal fat or stomach content.](https://figures.cochat.ai/paper-figures/828414b239864689856398b605c91aa9/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-5.jpg)
![Figure 6 No inducible TSPO ligand binding in Tspo−/− mice. (a,b) TSPO-binding ligands PK11195 and CLINDE/PBR111. (c) Axotomy of the facial nerve induces a retrograde neuronal reaction and highly reproducible microglial activation in the injured facial nucleus. (d) Autoradiography with [3H]PK11195 and [125I]CLINDE and immunohistochemical staining of the microglial activation marker CD11b on consecutive brain sections confirmed the previously reported localized induction of TSPO ligand binding in the injured facial nucleus contemporaneous to the activation of microglia of Tspo+/+ animals. (e) In contrast, no binding of [3H]PK11195 and [125I]CLINDE could be induced in Tspo−/− mice despite the undiminished presence of activated microglia in the injured facial nucleus, thus providing evidence that the high selectivity of [3H]PK11195 and [125I]CLINDE for their respective binding sites on the TSPO is retained in pathologically changed tissue. (f) Immunofluorescent anti-CD11b staining of activated microglia in the injured facial nucleus of Tspo−/− mice revealed no obvious differences in microglial activation, with its characteristic localization of activated, perineuronal microglia, here (g) shown as higher magnification of the above section. Scale bars in (d,e) and the left image of (f) denote 1 mm, and that in the right image of (f) and in (g) 100 μm. The asterixes in (g and f) indicates the soma of neurons.](https://figures.cochat.ai/paper-figures/08195277d3b642a9b15a0cc6240331c0/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-6.jpg)
![Figure 7 PBR/TSPO-expressing brain tumour in global Tspo−/− mouse brain. (a) [18F]PBR111 PET/CT demonstrates a high-contrast signal confined exclusively to the Tspo+/+ brain tumour, while Tspo−/− surrounding brain shows no ligand binding. (b,c) For the same animal shown in (a), in vitro autoradiography with [3H]PK11195 (b) and subsequent immunohistochemical staining with anti-TSPO antibody on the same brain sections (c) confirm that PBR/TSPO ligand binding is strictly limited to the brain tumour region and no PBR/TSPO binding or recognition sites are present in Tspo−/− tissue. Scale bars, 1 mm. The PET images show the time frame from 5 to 10 min after injection and scaling is 0–5.3% ID per cm3 for (a).](https://figures.cochat.ai/paper-figures/a92691c829424c68a30a0871b1244114/positron-emission-tomography-and-functional-characterization-of-a-complete-pbr-figure-7.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent genetic mouse models in which TSPO had been deleted tissue specifically and globally have yielded conflicting results regarding steroidogenesis, ranging from no effect on steroidogenesis to severe compromise of ACTH-stimulated production of corticosterone (129–131).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [130]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Assessing mitochondrial dysfunction in cells
Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,405
The Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536
Current protocols in immunology
Nezlin, R. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,408
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Self-citationRupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Self-citationStocco, D. M., Wang, X., Jo, Y., & Manna, P. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0532 · Cited by 538
Enigma of the peripheral benzodiazepine receptor
Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G., & Weizman, A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01424-8 · Cited by 512
Cited by
Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential
Inoue, K., & Tsuda, M. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.2 · Cited by 908
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095023 · Cited by 337
Microglia in Retinal Degeneration
Rashid, K., Akhtar-Schaefer, I., & Langmann, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01975 · Cited by 355
Neuroinflammation in Neurodegenerative Disorders-a Review
Schain, M., & Kreisl, W. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0733-2 · Cited by 301
Werry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
Steroidogenesis: Unanswered Questions
Miller, W. L. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.09.002 · Cited by 226
The 18 kDa Translocator Protein, Microglia and Neuroinflammation
Liu, G., Middleton, R. J., Hatty, C. R., Kam, W. W., Chan, R., Pham, T., Harrison‐Brown, M., Dodson, E., Veale, K., & Banati, R. B. (2014) · Brain Pathology · doi:10.1111/bpa.12196 · Cited by 211
Self-citationIn Vivo Imaging of Human Neuroinflammation
Albrecht, D. S., Granziera, C., Hooker, J. M., & Loggia, M. L. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00056 · Cited by 208
Disorders in the initial steps of steroid hormone synthesis
Miller, W. L. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.009 · Cited by 205
Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
Notter, T., Coughlin, J. M., Gschwind, T., Weber-Stadlbauer, U., Wang, Y., Kassiou, M., Vernon, A. C., Benke, D., Pomper, M. G., Sawa, A., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.248 · Cited by 190
The impact of high and low dose ionising radiation on the central nervous system
Betlazar, C., Middleton, R. J., Banati, R. B., & Liu, G.-J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.002 · Cited by 187
Self-citationOwen, D. R., Narayan, N., Wells, L., Healy, L., Smyth, E., Rabiner, E. A., Galloway, D., Williams, J. B., Lehr, J., Mandhair, H., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17710182 · Cited by 194
“Various potentially relevant alternative functional roles have been described, including roles in the regulation of the efficiency of mitochondrial oxidative phosphorylation and the production of ROS.23,25 The latter might contribute to potential immunoregulatory functions, e.g. through modulation of ROS activation of…”
BackgroundCellular sources of TSPO expression in healthy and diseased brain
Nutma, E., Ceyzériat, K., Amor, S., Tsartsalis, S., Millet, P., Owen, D. R., Papadopoulos, V., & Tournier, B. B. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05166-2 · Cited by 192
Porcu, P., Barron, A. M., Frye, C. A., Walf, A. A., Yang, S. ‐., He, X. ‐., Morrow, A. L., Panzica, G. C., & Melcangi, R. C. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12351 · Cited by 171
Selective, high-contrast detection of syngeneic glioblastoma in vivo
Banati, R. B., Wilcox, P., Xu, R., Yin, G., Si, E., Son, E. T., Shimizu, M., Holsinger, R. M. D., Parmar, A., Zahra, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67036-z · Cited by 183
Self-citationIntracellular Cholesterol Trafficking and Impact in Neurodegeneration
Arenas, F., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00382 · Cited by 158
Mitochondrial cholesterol import
Elustondo, P., Martin, L. A., & Karten, B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.08.012 · Cited by 159
Yim, A., Smith, C., & Brown, A. M. (2022) · Immunological Reviews · doi:10.1111/imr.13081 · Cited by 153
Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders
Slominski, R. M., Tuckey, R. C., Manna, P. R., Jetten, A. M., Postlethwaite, A., Raman, C., & Slominski, A. T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0096-6 · Cited by 155
Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
Notter, T., Coughlin, J. M., Sawa, A., & Meyer, U. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.232 · Cited by 156
Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis
Papadopoulos, V., Aghazadeh, Y., Fan, J., Campioli, E., Zirkin, B., & Midzak, A. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.03.014 · Cited by 127
The Translocator Protein (TSPO) in Mitochondrial Bioenergetics and Immune Processes
Betlazar, C., Middleton, R. J., Banati, R., & Liu, G.-J. (2020) · Cells · doi:10.3390/cells9020512 · Cited by 129
Self-citationMECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
The changing landscape in translocator protein (TSPO) function
Selvaraj, V., & Stocco, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.02.007 · Cited by 126
Fan, J., Campioli, E., Midzak, A., Culty, M., & Papadopoulos, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502670112 · Cited by 133
“Similar comparisons of the viability of our Amhr2-,Tspo mice and that of the previously reported whole-body Tspo deletion mutants (18, 19) can be made, although differing methodologies make direct comparisons a challenge.”
BackgroundResultMicroglial Phenotypes and Functions in Multiple Sclerosis
O’Loughlin, E., Madore, C., Lassmann, H., & Butovsky, O. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028993 · Cited by 124
Plavén-Sigray, P., Matheson, G. J., Collste, K., Ashok, A. H., Coughlin, J. M., Howes, O. D., Mizrahi, R., Pomper, M. G., Rusjan, P., Veronese, M., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.1171 · Cited by 123
Fairley, L. H., Lai, K. O., Wong, J. H., Chong, W. J., Vincent, A. S., D’Agostino, G., Wu, X., Naik, R. R., Jayaraman, A., Langley, S. R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209177120 · Cited by 128
Translocator protein (18 kDa): an update on its function in steroidogenesis
Papadopoulos, V., Fan, J., & Zirkin, B. R. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12500 · Cited by 130
Betlazar, C., Harrison-Brown, M., Middleton, R., Banati, R., & Liu, G.-J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092707 · Cited by 124
“The current study establishes the constitutive distribution of TSPO in the normal mouse brain using a TSPO antibody, the specificity of which has been confirmed in a viable TSPO knockout model [3].”
BackgroundMethodInfluentialSelf-citationTranslocator Protein 18 kDa (TSPO): An Old Protein with New Functions?
Li, F., Liu, J., Liu, N., Kuhn, L. A., Garavito, R. M., & Ferguson-Miller, S. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00142 · Cited by 112
Current knowledge on the acute regulation of steroidogenesis
Selvaraj, V., Stocco, D. M., & Clark, B. J. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy102 · Cited by 118
Neuronal activity increases translocator protein (TSPO) levels
Notter, T., Schalbetter, S. M., Clifton, N. E., Mattei, D., Richetto, J., Thomas, K., Meyer, U., & Hall, J. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0745-1 · Cited by 118
Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies
Midzak, A., & Papadopoulos, V. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00106 · Cited by 114
Liu, B., Le, K. X., Park, M.-A., Wang, S., Belanger, A. P., Dubey, S., Frost, J. L., Holton, P., Reiser, V., Jones, P. A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0996-15.2015 · Cited by 114
“Although Banati et al. (2014) recently reported that 11C-PK11195 bound TSPO specifically and selectively in WT mice versus TSPO knock-out mice, other studies have indicated that 11C-PK11195 may not be an ideal PET tracer due to its low specificity and signal-to-noise ratio and short half-life ( 20…”
BackgroundThe microglia in healthy and diseased retina
Li, L., Eter, N., & Heiduschka, P. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.020 · Cited by 112
A role for TSPO in mitochondrial Ca2+ homeostasis and redox stress signaling
Gatliff, J., East, D. A., Singh, A., Alvarez, M. S., Frison, M., Matic, I., Ferraina, C., Sampson, N., Turkheimer, F., & Campanella, M. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.186 · Cited by 108
Sifting through the surfeit of neuroinflammation tracers
Cumming, P., Burgher, B., Patkar, O., Breakspear, M., Vasdev, N., Thomas, P., Liu, G.-J., & Banati, R. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17748786 · Cited by 111
Self-citationPannell, M., Economopoulos, V., Wilson, T. C., Kersemans, V., Isenegger, P. G., Larkin, J. R., Smart, S., Gilchrist, S., Gouverneur, V., & Sibson, N. R. (2020) · Glia · doi:10.1002/glia.23716 · Cited by 109
“TSPO is widely expressed in mammalian tissue, particularly in steroidproducing tissues, and it has numerous functions including immunomodulation, regulation of apoptosis, cell proliferation, and steroidogenesis (Banati et al., 2014).”
BackgroundTSPO: An Evolutionarily Conserved Protein with Elusive Functions
Bonsack, F., & Sukumari-Ramesh, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061694 · Cited by 97
TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis
Owen, D. R., Fan, J., Campioli, E., Venugopal, S., Midzak, A., Daly, E., Harlay, A., Issop, L., Libri, V., Kalogiannopoulou, D., et al. (2017) · Biochemical Journal · doi:10.1042/bcj20170648 · Cited by 93
Translocator Protein (TSPO) Affects Mitochondrial Fatty Acid Oxidation in Steroidogenic Cells
Tu, L. N., Zhao, A. H., Hussein, M., Stocco, D. M., & Selvaraj, V. (2016) · Endocrinology · doi:10.1210/en.2015-1795 · Cited by 94
PK11195 Effect on Steroidogenesis Is Not Mediated Through the Translocator Protein (TSPO)
Tu, L. N., Zhao, A. H., Stocco, D. M., & Selvaraj, V. (2015) · Endocrinology · doi:10.1210/en.2014-1707 · Cited by 94
Fu, Y., Wang, D., Wang, H., Cai, M., Li, C., Zhang, X., Chen, H., Hu, Y., Zhang, X., Ying, M., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz183 · Cited by 118
Augmented expression of TSPO after intracerebral hemorrhage: a role in inflammation?
Bonsack, F., Alleyne, C. H., & Sukumari-Ramesh, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0619-2 · Cited by 90
Shi, Y., Cui, M., Ochs, K., Brendel, M., Strübing, F., Briel, N., Eckenweber, F., Zou, C., Banati, R. B., Liu, G. J., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01013-9 · Cited by 94
Self-citationQuantitative PET in the 2020s: a roadmap
Meikle, S. R., Sossi, V., Roncali, E., Cherry, S. R., Banati, R. B., Mankoff, D. A., Jones, T., James, M. L., Sutcliffe-Goulden, J., Ouyang, J., et al. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/abd4f7 · Cited by 99
Self-citationMinireview: Translocator Protein (TSPO) and Steroidogenesis: A Reappraisal
Selvaraj, V., Stocco, D. M., & Tu, L. N. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1033 · Cited by 81
A brief history of the search for the protein(s) involved in the acute regulation of steroidogenesis
Stocco, D. M., Zhao, A. H., Tu, L. N., Morohaku, K., & Selvaraj, V. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.036 · Cited by 90
Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells
Bader, S., Wolf, L., Milenkovic, V. M., Gruber, M., Nothdurfter, C., Rupprecht, R., & Wetzel, C. H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.03.029 · Cited by 72
Thalamic inflammation after brain trauma is associated with thalamo-cortical white matter damage
Scott, G., Hellyer, P. J., Ramlackhansingh, A. F., Brooks, D. J., Matthews, P. M., & Sharp, D. J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0445-y · Cited by 78
Endozepines and their receptors: Structure, functions and pathophysiological significance
Tonon, M.-C., Vaudry, H., Chuquet, J., Guillebaud, F., Fan, J., Masmoudi-Kouki, O., Vaudry, D., Lanfray, D., Morin, F., Prevot, V., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.008 · Cited by 71
TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria
Gatliff, J., & Campanella, M. (2016) · Biochemical Journal · doi:10.1042/bj20150899 · Cited by 84
Imaging neuroinflammation in multiple sclerosis using TSPO-PET
Airas, L., Rissanen, E., & Rinne, J. O. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0147-6 · Cited by 70
Airas, L., Nylund, M., & Rissanen, E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00181 · Cited by 71
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
Ammer, L.-M., Vollmann‐Zwerenz, A., Ruf, V., Wetzel, C. H., Riemenschneider, M. J., Albert, N. L., Beckhove, P., & Hau, P. (2020) · Cancers · doi:10.3390/cancers12102973 · Cited by 80
Functional gains in energy and cell metabolism after TSPO gene insertion
Liu, G.-J., Middleton, R. J., Kam, W. W.-Y., Chin, D. Y., Hatty, C. R., Chan, R. H. Y., & Banati, R. B. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1281477 · Cited by 68
Self-citationSteroidogenic abnormalities in translocator protein knockout mice and significance in the aging male
Barron, A. M., Ji, B., Kito, S., Suhara, T., & Higuchi, M. (2018) · Biochemical Journal · doi:10.1042/bcj20170645 · Cited by 70
Lloyd-Evans, E., & Waller-Evans, H. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200043 · Cited by 69
Lost in translocation: the functions of the 18-kD translocator protein
Gut, P., Zweckstetter, M., & Banati, R. B. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.04.001 · Cited by 70
Self-citationTSPO Finds NOX2 in Microglia for Redox Homeostasis
Guilarte, T. R., Loth, M. K., & Guariglia, S. R. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.02.008 · Cited by 64
Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update
Gouilly, D., Saint‐Aubert, L., Ribeiro, M., Salabert, A., Tauber, C., Péran, P., Arlicot, N., Pariente, J., & Payoux, P. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15613 · Cited by 63
Gong, J., Szego, É. M., Leonov, A., Benito, E., Becker, S., Fischer, A., Zweckstetter, M., Outeiro, T., & Schneider, A. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2070-18.2019 · Cited by 66
Leydig Cell and Spermatogenesis
Ge, R., Li, X., & Wang, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-77779-1_6 · Cited by 76
Rupprecht, R., Wetzel, C. H., Dorostkar, M. M., Herms, J. W., Albert, N. L., Schwarzbach, J. V., Schumacher, M., & Neumann, I. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01561-3 · Cited by 73
Edison, P., & Brooks, D. J. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179929 · Cited by 61
Control of Neuroinflammation through Radiation-Induced Microglial Changes
Boyd, A., Byrne, S., Middleton, R. J., Banati, R. B., & Liu, G. J. (2021) · Cells · doi:10.3390/cells10092381 · Cited by 68
Self-citationEnigmatic Translocator protein (TSPO) and cellular stress regulation
Batoko, H., Veljanovski, V., & Jurkiewicz, P. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.07.001 · Cited by 67
TSPO is a REDOX regulator of cell mitophagy
Gatliff, J., & Campanella, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150037 · Cited by 65
Milenkovic, V. M., Slim, D., Bader, S., Koch, V., Heinl, E.-S., Alvarez-Carbonell, D., Nothdurfter, C., Rupprecht, R., & Wetzel, C. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133359 · Cited by 62
Mitochondrial Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis
Zhao, A. H., Tu, L. N., Mukai, C., Sirivelu, M. P., Pillai, V. V., Morohaku, K., Cohen, R., & Selvaraj, V. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686360 · Cited by 55
Biswas, L., Farhan, F., Reilly, J., Bartholomew, C., & Shu, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123740 · Cited by 60
An update into the medicinal chemistry of translocator protein (TSPO) ligands
Barresi, E., Robello, M., Costa, B., Pozzo, E. D., Baglini, E., Salerno, S., Settimo, F. D., Martini, C., & Taliani, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112924 · Cited by 62
Liang, J. J., & Rasmusson, A. M. (2018) · Chronic Stress · doi:10.1177/2470547018818555 · Cited by 61
Perivascular space dysfunction in cerebral small vessel disease is related to neuroinflammation
Hong, H., Tozer, D. J., Chen, Y., Brown, R. B., Low, A., & Markus, H. S. (2024) · Brain · doi:10.1093/brain/awae357 · Cited by 54
Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile
Wang, H., Zhai, K., Xue, Y., Yang, J., Yang, Q., Fu, Y., Hu, Y., Liu, F., Wang, W., Cui, L., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167307 · Cited by 49
Fan, J., Wang, K. Z., Zirkin, B. R., & Papadopoulos, V. (2017) · Endocrinology · doi:10.1210/en.2017-03065 · Cited by 57
Mages, K., Graßmann, F., Jägle, H., Rupprecht, R., Weber, B. H. F., Hauck, S. M., & Grosche, A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1424-5 · Cited by 52
Regulation of Mitochondrial, Cellular, and Organismal Functions by TSPO
Gavish, M., & Veenman, L. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.09.004 · Cited by 51
TSPO PIGA Ligands Promote Neurosteroidogenesis and Human Astrocyte Well-Being
Pozzo, E. D., Giacomelli, C., Costa, B., Cavallini, C., Taliani, S., Barresi, E., Settimo, F. D., & Martini, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071028 · Cited by 50
Kim, T., & Pae, A. N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1230606 · Cited by 49
Translocator protein: pharmacology and steroidogenesis
Midzak, A. S., Zirkin, B. R., & Papadopoulos, V. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150061 · Cited by 46
Kosek, E., Martinsen, S., Gerdle, B. U. C., Mannerkorpi, K., Löfgren, M., Bilevičiūtė-Ljungar, I., Fransson, P., Schalling, M., Ingvar, M., Ernberg, M. M., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.150 · Cited by 50
A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury
Li, H.-D., Li, M., Shi, E., Jin, W.-N., Wood, K., Gonzales, R., & Liu, Q. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0921-7 · Cited by 39
Barron, A. M., Higuchi, M., Hattori, S., Kito, S., Suhara, T., & Ji, B. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02136-5 · Cited by 46
Structural Integrity of the A147T Polymorph of Mammalian TSPO
Jaremko, M., Jaremko, Ł., Giller, K., Becker, S., & Zweckstetter, M. (2015) · ChemBioChem · doi:10.1002/cbic.201500217 · Cited by 44
Structure of the mammalian TSPO/PBR protein
Jaremko, M., Jaremko, Ł., Jaipuria, G., Becker, S., & Zweckstetter, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150029 · Cited by 43
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection
Pozzo, E. D., Giacomelli, C., Barresi, E., Costa, B., Taliani, S., Settimo, F. D., & Martini, C. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150028 · Cited by 45
Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia
Kreisl, W. C., Henter, I. D., & Innis, R. B. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.08.004 · Cited by 38
P450 Enzymes in Steroid Processing
Auchus, R. J., & Miller, W. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_12 · Cited by 44
Current status and future perspectives: TSPO in steroid neuroendocrinology
Selvaraj, V., & Tu, L. N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0241 · Cited by 40
Arbo, B. D., Benetti, F., García‐Segura, L. M., & Ribeiro, M. F. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.007 · Cited by 45
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Dinesh, A. A., Islam, J., Khan, J., Turkheimer, F., & Vernon, A. C. (2020) · CNS Drugs · doi:10.1007/s40263-020-00765-x · Cited by 41
Lière, P., Pianos, A., Oudinet, J., Schumacher, M., & Akwa, Y. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.022 · Cited by 42
Mitochondrial Translocator Protein (TSPO) Expression in the Brain After Whole Body Gamma Irradiation
Betlazar, C., Middleton, R. J., Howell, N. R., Storer, B., Davis, E., Davies, J. B., Banati, R. B., & Liu, G.-J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715444 · Cited by 38
Self-citationNeuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy
Fairley, L. H., Sahara, N., Aoki, I., Ji, B., Suhara, T., Higuchi, M., & Barron, A. M. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02122-1 · Cited by 39
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis
Daugherty, D. J., Chechneva, O., Mayrhofer, F., & Deng, W. (2016) · Scientific Reports · doi:10.1038/srep22556 · Cited by 36
Conformational Flexibility in the Transmembrane Protein TSPO
Jaremko, Ł., Jaremko, M., Giller, K., Becker, S., & Zweckstetter, M. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502314 · Cited by 39
Cytokine Signalling at the Microglial Penta-Partite Synapse
Aramideh, J. A., Vidal-Itriago, A., Morsch, M., & Graeber, M. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413186 · Cited by 35
Self-citationTranslocator protein and steroidogenesis
Costa, B., Pozzo, E. D., & Martini, C. (2018) · Biochemical Journal · doi:10.1042/bcj20170766 · Cited by 35
Metadata
- Authors
- Banati, R. B., Middleton, R. J., Chan, R., Hatty, C. R., Wai-Ying Kam, W., Quin, C., Graeber, M. B., Parmar, A., Zahra, D., Callaghan, P., Fok, S., Howell, N. R., Gregoire, M., Szabo, A., Pham, T., Davis, E., & Liu, G.-J.
- Affiliations
- The University of Sydney (AU)
- Australian Nuclear Science and Technology Organisation (AU)
- Corresponding author
- Banati, Richard B.
- Liu, Guo-Jun
- ORCID
- Venue
- Nature Communications
- Published
- 2014-11-19
- Volume
- 5
- Issue
- 1
- Pages
- 5452-5452
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4263137
- OpenAlex
- W1986304241
- Cited by
- 241
- References
- 43
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 18 · 2020: 30 · 2019: 20 · 2018: 19 · 2017: 26 · 2016: 30 · 2015: 31 · 2014: 2
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- The Australian Nuclear Science and Technology Organisation Institutional Repository (The Australian Nuclear Science and Technology Organisation) (submittedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion)
- Funders
- Australian Nuclear Science and Technology Organisation
- University of Sydney
- Cure Brain Cancer Foundation
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- translocator protein (TSPO), cholesterol transport, steroidogenesis, neuroinflammation biomarkers, PK11195, imidazopyridines, drug selectivity, fertility
- MeSH terms
- Adenosine Triphosphate, Adrenal Glands, Animals, Behavior, Animal, Brain, Cholesterol, Fertility, Kidney, Male, Mice, Inbred C57BL, Pregnenolone, Protoporphyrins, Spleen, Testis, Microglia, Receptors, GABA, Mice, Knockout, Positron-Emission Tomography, Mice, Whole Body Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.